Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

  • Lee & Hebert-Dufresne Publish SARS-CoV-2 Transmission Model for School Opening
    November 20, 2020 by Jennifer Nachbur
    Can schools safely remain open or reopen during periods of significant community spread of COVID-19? According to predictions from a UVM model of SARS-CoV-2 transmission in the school setting, yes – if appropriate precautions are followed both in school and in the community.
  • Villanti, Copeland Named to List of World’s Most Influential Researchers
    November 19, 2020 by Jeff Wakefield
    UVM faculty members Andrea Villanti, Ph.D., M.P.H., associate professor of psychiatry, and William Copeland, Ph.D., professor of psychiatry, have been named to a list of the world’s most influential researchers - the Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • Developing a COVID-19 Vaccine: Q&A with Beth Kirkpatrick, M.D.
    November 16, 2020 by Erin Post
    An internationally recognized physician-scientist, Beth Kirkpatrick, M.D., has a decades-long history of leadership in the field of vaccine testing and development. In 2001, she launched the UVM Vaccine Testing Center (VTC), and since then, the VTC has grown to assume a prominent role in the development and evaluation of vaccines for globally important infectious diseases. The VTC has garnered support from the National Institutes of Health, the Bill & Melinda Gates Foundation, and the U.S. Department of Defense, among others. Kirkpatrick is also principal investigator and director of UVM’s Translational Global Infectious Disease Research Center of Biomedical Research Excellence and Chair of the Department of Microbiology and Molecular Genetics.
  • Weiss Receives ALA Grant to Study COVID-19 Lung Damage
    November 13, 2020 by Jennifer Nachbur
    University of Vermont Professor of Medicine Daniel Weiss, M.D., Ph.D., has been selected to receive one of the inaugural American Lung Association COVID-19 Action Initiative's COVID-19 and Respiratory Virus Research Award.
  • Hudziak Featured in National Geographic Regarding Music as Tool for Kids' Pandemic Stress
    November 6, 2020 by User Not Found
    (NOVEMBER 6, 2020) James Hudziak, M.D., Director of the Vermont Center for Children, Youth and Families, creator and director of the UVM Wellness Environment (WE), and professor of psychiatry, was quoted in a National Geographic article, titled "Why Music Might be the Perfect Tool to Decrease Kids' Pandemic Stress."
  • Important COVID-19 Update From Dean Page
    November 6, 2020 by Richard L. Page
  • Research Excellence Highlighted at Fifth Annual Celebration
    November 5, 2020 by Michelle Bookless
    The Larner College of Medicine hosted the fifth annual "Dean's Celebration of Excellence in Research" on November 4 and 5. The two-day event highlighted the research being conducted by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
  • College Remembers Helen Moray Larner (1925--2020)
    November 4, 2020 by Ed Neuert
    The Larner College of Medicine lost one of its most steadfast and consequential supporters with the passing of Helen Moray Larner, wife of the late Robert Larner, M.D., on November 2, 2020.
  • Contingency Management Gains National Media Attention
    October 30, 2020 by Nicole Twohig
    A recent article in the New York Times, “This Addiction Treatment Works. Why Is It So Underused?” sought to examine why CM is not being implemented in treatment programs throughout the United States.
  • Rawson Comments on Addiction Treatment in New York Times
    October 27, 2020 by User Not Found
    (OCTOBER 27, 2020) Professor of Psychiatry Richard Rawson, Ph.D., was quoted in a New York Times article, titled "This Addiction Treatment Works. Why Is It So Underused?"
  • UVM and UVM Health Network Participate in Phase 3 COVID-19 Vaccine Trial
    October 27, 2020 by Neal Goswami
    The University of Vermont Medical Center and Vaccine Testing Center at the University of Vermont’s Larner College of Medicine have been selected to take part in a Phase 3 trial for a COVID-19 vaccine developed by Oxford University and manufactured by AstraZeneca.
  • Study Finds Lowering Nicotine Reduces Smoking Addictiveness in Vulnerable Populations
    October 20, 2020 by Nicole Twohig
    A JAMA Network Open study, led by Stephen T. Higgins, Ph.D., director of the Vermont Center on Behavior and Health at the University of Vermont’s Larner College of Medicine, provides evidence that, even in smokers from vulnerable populations, reducing nicotine content to low levels decreases addictiveness – a timely finding as the Food and Drug Administration (FDA) considers a policy to lower nicotine content in all cigarettes sold in the U.S.
  • Study Finds Lowering Nicotine Reduces Smoking Addictiveness in Vulnerable Populations
    October 20, 2020 by Nicole Twohig
    A JAMA Network Open study, led by Stephen T. Higgins, Ph.D., director of the Vermont Center on Behavior and Health at the University of Vermont’s Larner College of Medicine, provides evidence that, even in smokers from vulnerable populations, reducing nicotine content to low levels decreases addictiveness – a timely finding as the Food and Drug Administration (FDA) considers a policy to lower nicotine content in all cigarettes sold in the U.S.
  • UVM Scientist Plays Lead Role in #BlackinCardio Campaign
    October 19, 2020 by Michelle Bookless
    Organized by Black physicians and scientists in the United States and abroad, the #BlackInCardio movement celebrates Black researchers, clinicians, and professionals in cardiovascular fields and raises awareness of cardiovascular diseases that disproportionately effect the Black community. From October 19 - October 25, the new organization will host its first annual #BlackInCardio week.
  • 8th Annual VCBH Conference
    October 16, 2020 by Nicole Twohig
    Last week, we held the 8th Annual VCBH Conference virtually due to COVID19. This year’s theme, Rural Addiction and Health, “could not be timelier with the emergence of COVID-19 and the ripple effects we have seen, from health disparities to increased opioid overdoses and the use of telemedicine,“ noted VCBH Director Stephen T. Higgins in his welcome letter to attendees.
  • Diehl & Colleagues Uncover Critical Information about COVID-19 Immune Response
    October 15, 2020 by Jennifer Nachbur
    New research, published in Clinical and Translational Immunology by UVM Associate Professor Sean Diehl, Ph.D., and colleagues provides a clearer picture of the protective antibodies induced by the SARS-C0V-2 virus and their role in serious illness and what’s needed for full protection.
  • Wojewoda Discusses COVID-19 Testing Roadblocks in MedPageToday
    October 15, 2020 by Jennifer Nachbur
    (OCTOBER 15, 2020) A MedPageToday article on the impact of pipette shortages on COVID-19 testing quotes Christina Wojewoda, M.D., associate professor of pathology and laboratory medicine.
  • High-Stakes Advocacy — James Metz, M.D., and his team work to keep every Vermont child safe
    October 14, 2020 by User Not Found
    “Ensuring children are empowered and raised to become healthy, happy, productive members of our communities is one of the most important things we can do,” says assistant professor of pediatrics at the University of Vermont Larner College of Medicine James Metz, M.D. “Child abuse needs to be brought out from the underbelly of society. It’s easy for people to say ‘the problem is too big; it’s too difficult; it’s too sad.’ But that’s when you need to step into a problem, not away from it.”
  • Majumdar Research Shows How SARS-CoV-2 Robs Cell’s Ability to Sound Alarm and Fight
    October 8, 2020 by Jennifer Nachbur
    New research, published by scientists at the University of Vermont and Caltech in the journal Cell, has pinpointed three specific mechanisms that allow SARS-CoV-2 to incapacitate human cells by disabling the cell’s alarm system to call for help or warn nearby cells of infection.
  • Nelson Delivers NIH Director’s Wednesday Afternoon Lecture
    October 7, 2020 by Jennifer Nachbur
    Internationally recognized cerebral blood flow expert and University of Vermont Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., delivered a National Institutes of Health (NIH) Director’s Wednesday Afternoon Lecture, titled “Translating Thought into Blood Flow in the Brain: Capillaries as Sensors of Neural Activity,” on October 14.